274 related articles for article (PubMed ID: 35899413)
21. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation.
Mohamed ME; Saqr A; Staley C; Onyeaghala G; Teigen L; Dorr CR; Remmel RP; Guan W; Oetting WS; Matas AJ; Israni AK; Jacobson PA
Transplantation; 2024 Feb; ():. PubMed ID: 38361239
[TBL] [Abstract][Full Text] [Related]
22. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?
Kaźmierczak-Siedlecka K; Bulman N; Ulasiński P; Sobocki BK; Połom K; Marano L; Kalinowski L; Skonieczna-Żydecka K
Gut Microbes; 2023 Dec; 15(2):2281017. PubMed ID: 37985748
[TBL] [Abstract][Full Text] [Related]
23. Novel Techniques and Models for Studying the Role of the Gut Microbiota in Drug Metabolism.
Tan J; Fu B; Zhao X; Ye L
Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):131-147. PubMed ID: 38123834
[TBL] [Abstract][Full Text] [Related]
24. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.
Feng W; Liu J; Ao H; Yue S; Peng C
Theranostics; 2020; 10(24):11278-11301. PubMed ID: 33042283
[TBL] [Abstract][Full Text] [Related]
25. The human microbiome in health and disease: hype or hope.
Falony G; Vandeputte D; Caenepeel C; Vieira-Silva S; Daryoush T; Vermeire S; Raes J
Acta Clin Belg; 2019 Apr; 74(2):53-64. PubMed ID: 30810508
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota: what is its place in pharmacology?
Tarasiuk A; Fichna J
Expert Rev Clin Pharmacol; 2019 Oct; 12(10):921-930. PubMed ID: 31544557
[No Abstract] [Full Text] [Related]
27. Pharmacomicrobiomics: a novel route towards personalized medicine?
Doestzada M; Vila AV; Zhernakova A; Koonen DPY; Weersma RK; Touw DJ; Kuipers F; Wijmenga C; Fu J
Protein Cell; 2018 May; 9(5):432-445. PubMed ID: 29705929
[TBL] [Abstract][Full Text] [Related]
28. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
29. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
Ghosh TS; Das M; Jeffery IB; O'Toole PW
Elife; 2020 Mar; 9():. PubMed ID: 32159510
[TBL] [Abstract][Full Text] [Related]
30. Gut-on-chip for ecological and causal human gut microbiome research.
Moossavi S; Arrieta MC; Sanati-Nezhad A; Bishehsari F
Trends Microbiol; 2022 Aug; 30(8):710-721. PubMed ID: 35190251
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health.
Fassarella M; Blaak EE; Penders J; Nauta A; Smidt H; Zoetendal EG
Gut; 2021 Mar; 70(3):595-605. PubMed ID: 33051190
[TBL] [Abstract][Full Text] [Related]
32. Predicting drug-microbiome interactions with machine learning.
McCoubrey LE; Gaisford S; Orlu M; Basit AW
Biotechnol Adv; 2022; 54():107797. PubMed ID: 34260950
[TBL] [Abstract][Full Text] [Related]
33. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
[TBL] [Abstract][Full Text] [Related]
34. Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.
Lam KN; Alexander M; Turnbaugh PJ
Cell Host Microbe; 2019 Jul; 26(1):22-34. PubMed ID: 31295421
[TBL] [Abstract][Full Text] [Related]
35. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
[TBL] [Abstract][Full Text] [Related]
36. A review of metabolic potential of human gut microbiome in human nutrition.
Yadav M; Verma MK; Chauhan NS
Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
[TBL] [Abstract][Full Text] [Related]
37. Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.
Saad R; Rizkallah MR; Aziz RK
Gut Pathog; 2012 Nov; 4(1):16. PubMed ID: 23194438
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiome Integration in Drug Discovery and Development of Small Molecules.
Jimonet P; Druart C; Blanquet-Diot S; Boucinha L; Kourula S; Le Vacon F; Maubant S; Rabot S; Van de Wiele T; Schuren F; Thomas V; Walther B; Zimmermann M;
Drug Metab Dispos; 2024 Mar; 52(4):274-287. PubMed ID: 38307852
[TBL] [Abstract][Full Text] [Related]
39. Ecophylogenetics Clarifies the Evolutionary Association between Mammals and Their Gut Microbiota.
Gaulke CA; Arnold HK; Humphreys IR; Kembel SW; O'Dwyer JP; Sharpton TJ
mBio; 2018 Sep; 9(5):. PubMed ID: 30206171
[TBL] [Abstract][Full Text] [Related]
40. Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment.
Chen HQ; Gong JY; Xing K; Liu MZ; Ren H; Luo JQ
Front Med (Lausanne); 2021; 8():742394. PubMed ID: 35127738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
